Access cutting-edge cardiac amyloidosis treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access cardiac amyloidosis specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cardiac amyloidosis treatment provided free
This is an open-label, multi-center pivotal Phase 3 study to visually and quantitatively assess PET images obtained after single application of 300 MBq \[18F\]florbetaben and PET scanning of patients with suspected cardiac amyloidosis.
Sponsor: Life Molecular Imaging GmbH
Check if you qualify for this cardiac amyloidosis clinical trial in Kansas City, KS
If you're searching for cardiac amyloidosis treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiac amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.